Detection and identification of human papillomavirus using a PCR-restriction fragment mass polymorphism assay

Molecular Medicine Reports

Volumn 4, Issue 4, 2011, Pages 645-650

  Lee, Jin Kyung ^a   Hong, Young Jun ^a   Um, Tae Hyun ^e   Lee, Eun Hee ^f   Chi, Hyun Sook ^b   Koh, Jae Soo ^a   Yim, Hyeon Woo ^c   Cha, Young Joo ^d  

^a Korea Cancer Center Hospital   (South Korea)

^b University of Ulsan College of Medicine   (South Korea)

^c The Catholic University of Korea College of Medicine   (South Korea)

^d Chung Ang University College of Medicine   (South Korea)

^e Inje University College of Medicine   (South Korea)

^f Green Cross Reference Laboratory   (South Korea)

Author keywords

Analytical sensitivity; Clinical sensitivity; Human papillomavirus; Multiple infection; Polymerase chain reaction restriction fragment mass polymorphism

Indexed keywords

ACCURACY; ARTICLE; CLINICAL EFFECTIVENESS; CLINICAL EVALUATION; CYTOLOGY; DNA SEQUENCE; GENOTYPE; HISTOLOGY; HUMAN PAPILLOMAVIRUS TYPE 11; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; INTERMETHOD COMPARISON; LIMIT OF DETECTION; POLYMERASE CHAIN REACTION; POLYMERASE CHAIN REACTION RESTRICTION FRAGMENT MASS POLYMORPHISM; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SENSITIVITY ANALYSIS; VIRUS DETECTION; VIRUS IDENTIFICATION;

DNA, VIRAL; FEMALE; GENOTYPE; HUMANS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; SEQUENCE ANALYSIS, DNA; UTERINE CERVICAL NEOPLASMS;

HUMAN PAPILLOMAVIRUS;

EID: 79957628334     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2011.475     Document Type: Article

References (20)

1. GLOBOCAN 2008, International Agency for Research on Cancer: Section for Cancer Information: Cervical Cancer Incidence and Mortality Worldwide in 2008. http://globocan.iarc.fr/factsheets/cancers/cervix.asp. Accessed Oct 16, 2010.
2. De Villiers EM, Fauquet C, Broker TR, et al: Classification of papillomaviruses. Virology 324: 17-27, 2004. (Pubitemid 38737395)
3. Munoz N, Bosch FX, de Sanjose S, et al: Epidemiologic classi- fication of human papillomavirus types associated with cervical cancer. N Engl J Med 348: 518-527, 2003. (Pubitemid 36159887)
4. Brown DR, Schroeder JM, Bryan JT, et al: Detection of multiple human papillomavirus types in Condylomata acuminata lesions from otherwise healthy and immunosuppressed patients. J Clin Microbiol 37: 3316-3322, 1999. (Pubitemid 29455226)
5. Gale N, Poljak M, Kambic V, et al: Laryngeal papillomatosis: molecular, histopathological, and clinical evaluation. Virchows Arch 425: 291-295, 1994. (Pubitemid 24368910)
6. Bosch FX, Burchell AN, Schiffman M, et al: Epidemiology and natural history of human papillomavirus infections and type-specific implications in cervical neoplasia. Vaccine 26 (Suppl 10): 1-16, 2008.
7. Hong SP, Kim NK, Hwang SG, et al: Detection of hepatitis B virus YMDD variants using mass spectrometric analysis of oligonucleotide fragments. J Hepatol 40: 837-844, 2004. (Pubitemid 38507366)
8. Lee CH, Kim SO, Byun KS, et al: Predominance of hepatitis B virus YMDD mutants is prognostic of viral DNA breakthrough. Gastroenterology 130: 1144-1152, 2006.
9. Kim HS, Han KH, Ahn SH, et al: Evaluation of methods for monitoring drug resistance in chronic hepatitis B patients during lamivudine therapy based on mass spectrometry and reverse hybridization. Antivir Ther 10: 441-449, 2005. (Pubitemid 41151022)
10. Kim YJ, Kim SO, Chung HJ, et al: Population genotyping of hepatitis C virus by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry analysis of short DNA fragments. Clin Chem 51: 1123-1131, 2005. (Pubitemid 43079388)
11. Hong SP, Shin SK, Lee EH, et al: High-resolution human papillomavirus genotyping by MALDI-TOF mass spectrometry. Nat Protoc 3: 1476-1484, 2008.
12. Gravitt PE, Peyton CL, Alessi TQ, et al: Improved amplification of genital human papillomaviruses. J Clin Microbiol 38: 357-361, 2000. (Pubitemid 30043317)
13. Lee EH, Chung HJ, Oh HB, et al: Human papillomavirus genotyping assay using restriction fragment mass polymorphism analysis, and its comparison with sequencing and hybrid capture assays. Korean J Lab Med 27: 62-68, 2007.
14. Qu W, Jiang G, Cruz Y, et al: PCR detection of human papillomavirus: comparison between MY09/MY11 and GP5+/GP6+ primer systems. J Clin Microbiol 35: 1304-1310, 1997. (Pubitemid 27216785)
15. Van Doorn LJ, Quint W, Kleter B, et al: Genotyping of human papillomavirus in liquid cytology cervical specimens by the PGMY line blot assay and the SPF (10) line probe assay. J Clin Microbiol 40: 979-983, 2002. (Pubitemid 34208655)
16. Kyrgiou M, Koliopoulos G, Martin-Hirsch P, et al: Obstetric outcomes after conservative treatment for intraepithelial or early invasive cervical lesions: systematic review and meta-analysis. Lancet 367: 489-498, 2006. (Pubitemid 43208905)
17. Snijders PJ, van den Brule AJ and Meijer CJ: The clinical relevance of human papillomavirus testing: relationship between analytical and clinical sensitivity. J Pathol 201: 1-6, 2003. (Pubitemid 37121197)
18. Ronco G, Ghisetti V, Segnan N, et al: Prevalence of human papillomavirus infection in women in Turin, Italy. Eur J Cancer 41: 297-305, 2005. (Pubitemid 40126963)
19. Clifford GM, Rana RK, Franceschi S, et al: Human papillomavirus genotype distribution in low-grade cervical lesions: comparison by geographic region and with cervical cancer. Cancer Epidemiol Biomarkers Prev 14: 1157-1164, 2005. (Pubitemid 40656461)
20. Ermel A, Qadadri B, Morishita A, et al: Human papillomavirus detection and typing in thin prep cervical cytologic specimens comparing the Digene Hybrid Capture II Assay, the Roche Linear Array HPV Genotyping Assay, and the Kurabo GeneSquare Microarray Assay. J Virol Methods 169: 154-161, 2010.